Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 20 Key Players companies in Dapagliflozin
by Highest Patent Value in the China in 2022

The Dapagliflozin top 20 is Discovery PatSnap’ annual ranking of the top 20 Highest Patent Value Dapagliflozin Key Players in the China. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
#
Company Name
Region
Tech Topics
Total
1
Biology,Medicine,Health care,
...[+2]
Avg patent value: 2.86 M
2
Avg patent value: 569,750
3
Avg patent value: 180,000
4
Avg patent value: 89,000
5
Avg patent value: 42,300
6
Medicine,Health care
Avg patent value: 42,300
7
Avg patent value: 3,566
8
Health care,Drugs production,Drug,
...[+2]
Avg patent value: 3,500
9
Fine chemical,Excipient,Health care,
...[+2]
Avg patent value: 3,500
10
Avg patent value: 3,500
11
Avg patent value: 3,500
12
Avg patent value: 3,500
13
Avg patent value: 3,500
14
Avg patent value: 3,450
15
Medicine,Health care,Exosome,
...[+2]
Avg patent value: 3,400
16
Avg patent value: 3,400
17
Avg patent value: 3,400
18
Avg patent value: 3,400
19
Avg patent value: 3,400
20
Avg patent value: 3,300
Page generation time: May 03 2025